- Home
- RCUS vs NRDS Comparison
RCUS vs NRDS Comparison
Compare RCUS & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- NRDS
- Stock Information
- Founded
- RCUS 2015
- NRDS 2009
- Country
- RCUS United States
- NRDS United States
- Employees
- RCUS N/A
- NRDS N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- NRDS EDP Services
- Sector
- RCUS Health Care
- NRDS Technology
- Exchange
- RCUS Nasdaq
- NRDS Nasdaq
- Market Cap
- RCUS 727.1M
- NRDS 616.0M
- IPO Year
- RCUS 2018
- NRDS 2021
- Fundamental
- Price
- RCUS $8.28
- NRDS $11.09
- Analyst Decision
- RCUS Buy
- NRDS Buy
- Analyst Count
- RCUS 11
- NRDS 6
- Target Price
- RCUS $25.33
- NRDS $15.17
- AVG Volume (30 Days)
- RCUS 1.2M
- NRDS 490.1K
- Earning Date
- RCUS 05-06-2025
- NRDS 05-06-2025
- Dividend Yield
- RCUS N/A
- NRDS N/A
- EPS Growth
- RCUS N/A
- NRDS N/A
- EPS
- RCUS N/A
- NRDS 0.38
- Revenue
- RCUS $141,000,000.00
- NRDS $734,900,000.00
- Revenue This Year
- RCUS N/A
- NRDS $12.65
- Revenue Next Year
- RCUS $25.77
- NRDS $8.37
- P/E Ratio
- RCUS N/A
- NRDS $29.37
- Revenue Growth
- RCUS N/A
- NRDS 24.20
- 52 Week Low
- RCUS $6.50
- NRDS $7.55
- 52 Week High
- RCUS $18.98
- NRDS $16.45
- Technical
- Relative Strength Index (RSI)
- RCUS 48.63
- NRDS 71.58
- Support Level
- RCUS $7.06
- NRDS $8.34
- Resistance Level
- RCUS $9.35
- NRDS $11.40
- Average True Range (ATR)
- RCUS 0.55
- NRDS 0.38
- MACD
- RCUS 0.06
- NRDS 0.31
- Stochastic Oscillator
- RCUS 53.28
- NRDS 89.87
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides onsumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.